BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 29050691)

  • 1. Philadelphia chromosome negative B-cell acute lymphoblastic leukemia in older adults: Current treatment and novel therapies.
    O'Dwyer KM; Liesveld JL
    Best Pract Res Clin Haematol; 2017 Sep; 30(3):184-192. PubMed ID: 29050691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Young Adults with Acute Lymphoblastic Leukemia.
    Kansagra A; Litzow M
    Curr Hematol Malig Rep; 2017 Jun; 12(3):187-196. PubMed ID: 28353017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How should we treat older adults with Ph+ adult ALL and what novel approaches are being investigated?
    Wieduwilt MJ
    Best Pract Res Clin Haematol; 2017 Sep; 30(3):201-211. PubMed ID: 29050693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blinatumomab compared with standard of care for the treatment of adult patients with relapsed/refractory Philadelphia chromosome-positive B-precursor acute lymphoblastic leukemia.
    Rambaldi A; Ribera JM; Kantarjian HM; Dombret H; Ottmann OG; Stein AS; Tuglus CA; Zhao X; Kim C; Martinelli G
    Cancer; 2020 Jan; 126(2):304-310. PubMed ID: 31626339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia.
    Brissot E; Labopin M; Beckers MM; Socié G; Rambaldi A; Volin L; Finke J; Lenhoff S; Kröger N; Ossenkoppele GJ; Craddock CF; Yakoub-Agha I; Gürman G; Russell NH; Aljurf M; Potter MN; Nagler A; Ottmann O; Cornelissen JJ; Esteve J; Mohty M
    Haematologica; 2015 Mar; 100(3):392-9. PubMed ID: 25527562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies: Immunoconjugates and autologous cellular therapy in acute lymphoblastic leukemia.
    Advani A
    Best Pract Res Clin Haematol; 2015; 28(2-3):116-23. PubMed ID: 26590768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase 2 study of intensified chemotherapy and allogeneic hematopoietic stem cell transplantation for older patients with acute lymphoblastic leukemia.
    Fathi AT; DeAngelo DJ; Stevenson KE; Kolitz JE; Asch JD; Amrein PC; Attar EC; Steensma DP; Wadleigh M; Foster J; Connolly C; Galinsky I; Devoe CE; Stone RM; Neuberg DS; Ballen KK
    Cancer; 2016 Aug; 122(15):2379-88. PubMed ID: 27171984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia in Adults.
    Speziali C; Paulson K; Seftel M
    Curr Hematol Malig Rep; 2016 Jun; 11(3):175-84. PubMed ID: 26984203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of philadelphia chromosome-positive acute lymphoblastic leukemia.
    Chen H; Liu KY; Xu LP; Chen YH; Han W; Zhang XH; Wang Y; Qin YZ; Liu YR; Huang XJ
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1110-6. PubMed ID: 25698612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Which patients should I transplant with acute lymphoblastic leukemia?
    Inbar T; Rowe JM; Horowitz NA
    Best Pract Res Clin Haematol; 2017 Sep; 30(3):249-260. PubMed ID: 29050698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How I treat adults with relapsed or refractory Philadelphia chromosome-negative acute lymphoblastic leukemia.
    Frey NV; Luger SM
    Blood; 2015 Jul; 126(5):589-96. PubMed ID: 25966988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Imatinib in combination with allogeneic hematopoietic stem cell transplantation improved the outcome of adult Philadelphia chromosome-positive acute lymphoblastic leukemia].
    Cheng Z; Zhao L; Chen G; Wu D; Qiu H; Tang X; Fu C; Jin Z; Chen F; Xue S; Sun A
    Zhonghua Xue Ye Xue Za Zhi; 2014 Feb; 35(2):114-9. PubMed ID: 24606651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Therapies in Acute Lymphoblastic Leukemia.
    Phelan KW; Advani AS
    Curr Hematol Malig Rep; 2018 Aug; 13(4):289-299. PubMed ID: 30078158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Additional Cytogenetic Abnormalities in Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation.
    Aldoss I; Stiller T; Cao TM; Palmer JM; Thomas SH; Forman SJ; Pullarkat V
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1326-9. PubMed ID: 25842050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does Post-Transplant Maintenance Therapy With Tyrosine Kinase Inhibitors Improve Outcomes of Patients With High-Risk Philadelphia Chromosome-Positive Leukemia?
    DeFilipp Z; Langston AA; Chen Z; Zhang C; Arellano ML; El Rassi F; Flowers CR; Kota VK; Al-Kadhimi Z; Veldman R; Jillella AP; Lonial S; Waller EK; Khoury HJ
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16(8):466-471.e1. PubMed ID: 27297665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adults with Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia: Considerations for Allogeneic Hematopoietic Cell Transplantation in First Complete Remission.
    Aldoss I; Kamal MO; Forman SJ; Pullarkat V
    Biol Blood Marrow Transplant; 2019 Feb; 25(2):e41-e45. PubMed ID: 30292743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the treatment of Philadelphia chromosome negative acute lymphoblastic leukemia.
    Burkart M; Dinner S
    Blood Rev; 2024 Jul; 66():101208. PubMed ID: 38734488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell-rich HLA-haploidentical hematopoietic stem cell transplantation for relapsed/refractory pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia without posttransplant tyrosine kinase inhibitor therapy.
    Sano H; Mochizuki K; Akaihata M; Kobayashi S; Ohto H; Kikuta A
    Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27781393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age but not Philadelphia positivity impairs outcome in older/elderly patients with acute lymphoblastic leukemia in Sweden.
    Kozlowski P; Lennmyr E; Ahlberg L; Bernell P; Hulegårdh E; Karbach H; Karlsson K; Tomaszewska-Toporska B; Åström M; Hallböök H;
    Eur J Haematol; 2017 Aug; 99(2):141-149. PubMed ID: 28419558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel immunotherapies in lymphoid malignancies.
    Batlevi CL; Matsuki E; Brentjens RJ; Younes A
    Nat Rev Clin Oncol; 2016 Jan; 13(1):25-40. PubMed ID: 26525683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.